Clinical Trial

Intravenous Regional Analgesia of Dexmedetomidine

Study acronym: Dexmedetomidin
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Dexmedetomidine is a highly selective α₂-adrenergic receptor agonist that exerts its effects by inhibiting the release of norepinephrine at presynaptic nerve terminals, leading to reduced sympathetic activity; This mechanism results in analgesia, sedation, and anxiolysis without significant respiratory depression
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-12.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-01-17
Trial Details
NCT Number NCT07131579
Lead Sponsor Mansoura University
Conditions Dexmedetomidine Analgesia, Knee Surgery
Enrollment 100 participants
Start Date 2026-01-12
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-21